In particular, the activation of the cyclic GMP-AMP synthase (cGAS)-STING pathway by cytosolic tumor DNA is essential for the formation of antitumor T effector cells and the efficacy of ICB therapy in preclinical cancer models [178]. The gene discussed is STING1; the disease is cancer.